Clinical Studies

      Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L

      First posted
      Aug 25, 2015
      Official Title

      A Single-center, Open-label, Ascending Nicotine Levels Study to Investigate the Nicotine Pharmacokinetic and Pharmacodynamics Profiles, Safety and Tolerability of P3L in Smoking Healthy Subjects in Relation to Nicorette® Inhalator

      Brief Summary

      The purpose of this study is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD, i.e., subjective effects) profiles, and the safety and tolerability of the nicotine-containing aerosol delivered by Platform 3 Liquid (P3L) system at three different nicotine levels in smoking healthy subjects in relation to Nicorette® inhalator.


      Recruitment: Completed

      Study Results: Available

      Enrollment: 16

      Study Type: Interventional

      Other IDs: P3L-PK-01-NZ